Literature DB >> 18253808

No increase in long-term risk for nicotine use disorders after treatment with methylphenidate in children with attention-deficit/hyperactivity disorder (ADHD): evidence from a non-randomised retrospective study.

M Huss1, F Poustka, G Lehmkuhl, U Lehmkuhl.   

Abstract

OBJECTIVE: To evaluate long-term effects of methylphenidate (MPH) treatment in ADHD children on the development of nicotine use disorders (SUD-N).
METHODS: Multisite retrospective non-randomised longitudinal study with 215 ADHD children (diagnosis at 9.2 years of age; reassessment for SUD-N at 21.9 years of age) strictly parallel allocated to MPH treated (n = 106) and drug naive (n = 109) children.
RESULTS: There was no difference between the groups with respect to frequency (84% MPH; 89% non-MPH; chi(2) = 1.6; p = 0.21) and age of onset for first cigarette smoking (log rank 1.68; p = 0.19). Continuous smoking was reached by 51% (MPH) and 61% (non-MPH) of the patients. Survival analyses revealed a small and nominally significant delay in age of onset for continuous smoking in the MPH-group (log rank = 3.85; p = 0.049). Nicotine dependency was reached by 20% (MPH) and 27% (non-MPH). Age of onset does not differ between groups (log rank = 2.24; p = 0.13). DISCUSSION: Limited evidence due to the non-randomised nature of the study is given that MPH does not induce SUD-N. The data suggests there may be a beneficial effect of MPH on delay of onset for continuous nicotine consumption in ADHD patients.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18253808     DOI: 10.1007/s00702-008-0872-3

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  18 in total

1.  ADHD and addiction.

Authors:  Trevor W Robbins
Journal:  Nat Med       Date:  2002-01       Impact factor: 53.440

2.  Nicotine: a gateway drug?

Authors:  M Jessup
Journal:  J Am Med Womens Assoc (1972)       Date:  1996 Jan-Apr

Review 3.  Methylphenidate and substance abuse: a review of pharmacology, animal, and clinical studies.

Authors:  M Huss; U Lehmkuhl
Journal:  J Atten Disord       Date:  2002       Impact factor: 3.256

4.  Hypescheme: an operational criteria checklist and minimum data set for molecular genetic studies of attention deficit and hyperactivity disorders.

Authors:  S Curran; S Newman; E Taylor; P Asherson
Journal:  Am J Med Genet       Date:  2000-06-12

5.  The Composite International Diagnostic Interview. An epidemiologic Instrument suitable for use in conjunction with different diagnostic systems and in different cultures.

Authors:  L N Robins; J Wing; H U Wittchen; J E Helzer; T F Babor; J Burke; A Farmer; A Jablenski; R Pickens; D A Regier
Journal:  Arch Gen Psychiatry       Date:  1988-12

6.  Is attention-deficit/hyperactivity disorder associated with illicit substance use disorders in male adolescents? A community-based case-control study.

Authors:  Claudia M Szobot; Luis A Rohde; Oscar Bukstein; Brooke S G Molina; Caroline Martins; Pauline Ruaro; Flávio Pechansky
Journal:  Addiction       Date:  2007-07       Impact factor: 6.526

7.  A randomized, placebo-controlled clinical trial of bupropion for the prevention of smoking in children and adolescents with attention-deficit/hyperactivity disorder.

Authors:  Michael C Monuteaux; Thomas J Spencer; Stephen V Faraone; Angela M Wilson; Joseph Biederman
Journal:  J Clin Psychiatry       Date:  2007-07       Impact factor: 4.384

Review 8.  Impact of ADHD and its treatment on substance abuse in adults.

Authors:  Timothy E Wilens
Journal:  J Clin Psychiatry       Date:  2004       Impact factor: 4.384

9.  Pharmacotherapy for attention-deficit/hyperactivity disorder (ADHD) decreases the risk for substance abuse: findings from a longitudinal follow-up of youths with and without ADHD.

Authors:  Joseph Biederman
Journal:  J Clin Psychiatry       Date:  2003       Impact factor: 4.384

10.  Prospective effects of attention-deficit/hyperactivity disorder, conduct disorder, and sex on adolescent substance use and abuse.

Authors:  Irene J Elkins; Matt McGue; William G Iacono
Journal:  Arch Gen Psychiatry       Date:  2007-10
View more
  9 in total

1.  Pathogenesis and pathophysiology of attention-deficit/hyperactivity disorder: from childhood to adulthood.

Authors:  M Gerlach; J Deckert; A Rothenberger; A Warnke
Journal:  J Neural Transm (Vienna)       Date:  2008       Impact factor: 3.575

2.  Effect of brain structure and function on reward anticipation in children and adults with attention deficit hyperactivity disorder combined subtype.

Authors:  Viola Kappel; Robert C Lorenz; Martina Streifling; Babette Renneberg; Ulrike Lehmkuhl; Andreas Ströhle; Harriet Salbach-Andrae; Anne Beck
Journal:  Soc Cogn Affect Neurosci       Date:  2014-10-22       Impact factor: 3.436

3.  Cigarette and cannabis use trajectories among adolescents in treatment for attention-deficit/hyperactivity disorder and substance use disorders.

Authors:  Kevin M Gray; Paula D Riggs; Sung-Joon Min; Susan K Mikulich-Gilbertson; Dipankar Bandyopadhyay; Theresa Winhusen
Journal:  Drug Alcohol Depend       Date:  2011-03-15       Impact factor: 4.492

4.  Reward processing in male adults with childhood ADHD--a comparison between drug-naïve and methylphenidate-treated subjects.

Authors:  Meline Stoy; Florian Schlagenhauf; Lorna Schlochtermeier; Jana Wrase; Brian Knutson; Ulrike Lehmkuhl; Michael Huss; Andreas Heinz; Andreas Ströhle
Journal:  Psychopharmacology (Berl)       Date:  2011-02-08       Impact factor: 4.530

5.  Tobacco smoking in individuals with attention-deficit hyperactivity disorder: epidemiology and pharmacological approaches to cessation.

Authors:  Kevin M Gray; Himanshu P Upadhyaya
Journal:  CNS Drugs       Date:  2009-08       Impact factor: 5.749

6.  Stimulant treatment of ADHD and cigarette smoking: a meta-analysis.

Authors:  Erin N Schoenfelder; Stephen V Faraone; Scott H Kollins
Journal:  Pediatrics       Date:  2014-05-12       Impact factor: 7.124

7.  Methylphenidate does not influence smoking-reinforced responding or attentional performance in adult smokers with and without attention deficit hyperactivity disorder (ADHD).

Authors:  Scott H Kollins; Erin Schoenfelder; Joseph S English; F Joseph McClernon; Rachel E Dew; Scott D Lane
Journal:  Exp Clin Psychopharmacol       Date:  2013-10       Impact factor: 3.157

8.  A systematic review of global publication trends regarding long-term outcomes of ADHD.

Authors:  Paul Hodgkins; L Eugene Arnold; Monica Shaw; Hervé Caci; Jennifer Kahle; Alisa G Woods; Susan Young
Journal:  Front Psychiatry       Date:  2012-01-18       Impact factor: 4.157

9.  Trend, characteristics, and pharmacotherapy of adults diagnosed with attention-deficit/hyperactivity disorder: a nationwide survey in Taiwan.

Authors:  Yu-Shian Cheng; Yu-Chiau Shyu; Sheng-Yu Lee; Shin-Sheng Yuan; Chun-Ju Yang; Kang-Chung Yang; Tung-Liang Lee; Liang-Jen Wang
Journal:  Neuropsychiatr Dis Treat       Date:  2017-03-01       Impact factor: 2.570

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.